Sat-18-07-2020, 21:22 PM
In Cosentyx Lilly had set itself a low bar; cross-trial comparisons suggest that two rival anti-IL-23s, Abbvie’s Skyrizi and Johnson & Johnson’s Tremfya, would have been harder for mirikizumab to beat.
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-17-07-2020, 20:43 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by jiml - Fri-17-07-2020, 21:14 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by JohnB - Sat-18-07-2020, 20:54 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Sun-19-07-2020, 11:25 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 06:10 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 11:41 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 12:04 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 12:07 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by D Foster - Sat-18-07-2020, 21:22 PM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 840 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
Happiness and psoriasis study | Fred | 7 | 1,637 |
Sun-18-08-2024, 20:44 PM Last Post: Caroline |
|
Pustular psoriasis study in France | Fred | 1 | 1,383 |
Mon-26-02-2024, 21:11 PM Last Post: Caroline |
|
Piclidenoson for psoriasis phase 3 results | Fred | 1 | 3,235 |
Fri-02-02-2024, 20:04 PM Last Post: Caroline |
|
Polymorphisms associated with Cosentyx | Fred | 6 | 2,959 |
Sun-07-01-2024, 11:01 AM Last Post: Caroline |